| 000 | 01864 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513220739.0 | ||
| 264 | 0 | _c20000928 | |
| 008 | 200009s 0 0 eng d | ||
| 022 | _a0006-2960 | ||
| 024 | 7 |
_a10.1021/bi000788y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeiss, K K | |
| 245 | 0 | 0 |
_aMolecular architecture of the mutagenic active site of human immunodeficiency virus type 1 reverse transcriptase: roles of the beta 8-alpha E loop in fidelity, processivity, and substrate interactions. _h[electronic resource] |
| 260 |
_bBiochemistry _cSep 2000 |
||
| 300 |
_a10684-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAmino Acid Substitution _xgenetics |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 | _aBase Pair Mismatch |
| 650 | 0 | 4 |
_aBinding Sites _xgenetics |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 |
_aDNA Primers _xchemistry |
| 650 | 0 | 4 | _aDideoxynucleotides |
| 650 | 0 | 4 |
_aGlutamine _xgenetics |
| 650 | 0 | 4 |
_aGlycine _xgenetics |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLac Operon |
| 650 | 0 | 4 |
_aLysine _xgenetics |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 |
_aProtein Processing, Post-Translational _xgenetics |
| 650 | 0 | 4 |
_aProtein Structure, Secondary _xgenetics |
| 650 | 0 | 4 |
_aRNA _xchemistry |
| 650 | 0 | 4 |
_aSubstrate Specificity _xgenetics |
| 650 | 0 | 4 | _aTemplates, Genetic |
| 650 | 0 | 4 |
_aThymine Nucleotides _xpharmacology |
| 650 | 0 | 4 |
_aTryptophan _xgenetics |
| 650 | 0 | 4 |
_aZidovudine _xanalogs & derivatives |
| 700 | 1 | _aIsaacs, S J | |
| 700 | 1 | _aTran, N H | |
| 700 | 1 | _aAdman, E T | |
| 700 | 1 | _aKim, B | |
| 773 | 0 |
_tBiochemistry _gvol. 39 _gno. 35 _gp. 10684-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/bi000788y _zAvailable from publisher's website |
| 999 |
_c10925451 _d10925451 |
||